Analyst Scott Henry works at ROTH and is focused on the Healthcare sector with 213 price targets and ratings documented since 2010 spanning on 21 stocks. Analyst's average stock valuation to be materialised ratio is 55.34% with an average time for price targets to be met of 163.63 days.
Most recent stock forecast was given on CPRX, Catalyst Pharmaceuticals, Inc at 24-Aug-2022.
Scott Henry best performing recommendations are on INVO.
The best stock recommendation documented was for INVO at 4/13/2022. The price target of $2 was fulfilled within 1 day with a profit of $0.06 (2.91%) receiving and performance score of 29.13.
Average potential price target upside